Last reviewed · How we verify
NCT05987228
Effects of Orally Administered Thymus Vulgaris Leaves on Memory, Anxiety, Depression, and Sleep Quality in University Students: A Randomized Controlled Trial
NA trial testing Thymus vulgaris in Memory Dysfunction in 86 participants. Completed in 1 December 2022.
1 December 2022
Quick facts
| Lead sponsor | The Hashemite University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | supportive care |
| Enrollment | 86 |
| Start date | 1 August 2022 |
| Primary completion | 1 December 2022 |
| Estimated completion | 1 December 2022 |
| Sites | 1 location across Jordan |
Drugs / interventions tested
- Thymus vulgaris
Conditions studied
- Memory Dysfunction — all drugs for Memory Dysfunction →
- Anxiety — all drugs for Anxiety →
- Depression — all drugs for Depression →
- Sleep — all drugs for Sleep →
Sponsor
The Hashemite University
Who can join
Adults 19 to 23, any sex, with Memory Dysfunction or Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Thymus vulgaris could potentially serve as a safer alternative to stimulant drugs for enhancing memory among university students. Furthermore, Thymus vulgaris may offer additional benefits in terms of reducing anxiety, depression, and improving sleep quality. However, it should be noted that the current research on the effects of orally administered Thymus vulgaris on the brain and nervous system is limited, and further studies are required to fully explore its potential advantages. Therefore, the purpose of this study is to investigate the effects of oral Thymus vulgaris on memory performance, anxiety, depression, and sleep quality in university students.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05987228
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other The Hashemite University trials
Trials by the same sponsor.
- NCT07454200 — Feasibility, Acceptability, and Effectiveness of a Hatha Yoga-in Patients Hospitalized for Schizophrenia · NA · not yet recruiting
- NCT07178288 — Assessment of Pressure Pain Threshold (PPT) and Conditioned Pain Modulation (CPM) After Effect in Patients With and With · NA · recruiting
- NCT07512843 — Acceptability and Efficacy of Group Reminiscence Intervention in a Sample of Patients With Schizophrenia · NA · completed
- NCT06821022 — The Impact of Pain Neuroscience Education on Physical Therapy Student's Knowledge, Attitudes, Beliefs, and Behaviours To · NA · completed
- NCT05999071 — Coriandrum Sativum Seeds Improve Memory, Alleviate Anxiety and Depression, and Enhance Sleep Quality in University Stude · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05987228 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Hashemite University
- Last refreshed: 14 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05987228.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing